Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization

American Journal of Pathology

Volumn 155, Issue 2, 1999, Pages 375-386

  Bigner, Sandra H ^a   Matthews, Mark R ^a   Rasheed, B K A ^a   Wiltshire, Rodney N ^a   Friedman, Henry S ^a   Friedman, Allan H ^a   Stenzel, Timothy T ^a   Dawes, Donald M ^a   McLendon, Roger E ^a   Bigner, Darell D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; GENE PRODUCT; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME 9P; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OLIGODENDROGLIOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0032801035     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65134-6     Document Type: Article

References (25)

1. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumours of the Central Nervous System, ed 2. WHO International Histological Classification of Tumours. New York, Springer-Verlag, 1993, pp 1-105
2. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, MacDonald DR, Ino Y, Ramsey DA, Louis DN: Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998, 90:1473-1479
3. Paleologos NA, Cairncross JG: Treatment of oligodendroglioma: an update. Neuro-Oncology 1999, 1:61-68
4. Friedman A, Cokgor I, Kerby T, Edwards S, Rich J, Stewart E, McLendon R, Affronti M, Rasheed K, Provenzale J, Colvin O, Bigner D, Zaknoen S, Fraass U, Dugan M, Friedman H: Phase II treatment of anaplastic oligodendroglioma and low grade glioma with Temodal. Proc Am Soc Clin Oncol 1999, 18:150a (abstract)
5. von Deimling A, Nage J, Bender B, Lenartz D, Schramm J, Louis DN, Weistler OD: Deletion mapping of chromosome 19 in human gliomas. Int J Cancer 1994, 57:676-680
6. Bello MJ, Vanquero J, de Campos JM, Kusak ME, Sarasa JL, Saez-Castresona J, Pestafia A, Rey JA: Molecular analysis of chromosome 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors. Int J Cancer 1994, 57:172-175
7. Bello MJ, Leone PE, Nebreda P, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Garcia Miguel P, Queizan A, Hernández-Moneo JL, Pestana A, Rey JA: Allelic status of chromosome 1 in neoplasms of the nervous system. Cancer Genet Cytogenet 1995, 83:160-164
8. Riefenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP: Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994, 145:1175-1190
9. Ritland S, Ganju V, Jenkins RB: Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma. Genes Chromosom Cancer 1995, 12:277-282
10. Weber RG, Sabel M, Reifenberger J, Sommer C, Oberstra J, Reifenberger G, Kiessling M, Cremer T: Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene 1996, 13:983-994
11. Blaeker H, Rasheed BK, McLendon RE, Friedman HS, Batra SK, Fuchs HE, Bigner SH: Microsatellite analysis of childhood brain tumors. Genes Chromosom Cancer 1996, 15:54-63
12. Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ, Look AT: Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res 1993, 53:5535-5541
13. He J, Allen JR, Collins VP, Allalunis-Turner MJ, Godgout R, Day RS 3rd, James CD: CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Res 1994, 54:5804-5807
14. Rasheed BKA, McLendon RE, Herndon JE, Friedman HS, Friedman AH, Bigner DD, Bigner S: Alterations of the TP53 gene in human gliomas. Cancer Res 1994, 54:1324-1330
15. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Walman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1994, 258:818-821
16. Wiltshire RN, Duray P, Bittner ML, Visahorpi T, Meltzer PS, Tuthill RJ, Liotta LA, Trent JM: Direct visualization of the clonal progression of primary cutaneous melanoma: application of tissue microdissection and comparative genomic hybridization. Cancer Res 1995, 55:3954-3957
17. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D: Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom Cancer 1994, 10:231-243
18. Ransom DT, Ritland SR, Jenkins RB, Scheithauer B, Kelly PJ, Kimmel DW: Loss of heterozygosity studies in human gliomas. Proc Am Assoc Cancer Res 1991, 32:302
19. von Deimling A, Louis DN, von Ammon K, Petersen I, Weistler O, Seizinger B: Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas. Cancer Res 1992, 52:4277-4279
20. Rasheed BKA, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD, Bigner SH: PTEN gene mutations are seen in high grade but not in low grade gliomas. Cancer Res 1997, 57: 4187-4190
21. Duerr EM, Rollbrocker B, Hayashi Y, Peters N, Meyer-Puttlitz B, Louis DN, Schramm J, Wiestler OD, Parsons R, Eng C, von Diemling A: PTEN mutations in gliomas and glioneuronal tumors. Oncogene 1998, 16:2259-2264
22. Maintz D, Fiedler K, Koopmann J, Rollbrocker B, Nechev S, Lenartz D, Stangl AP, Louis DN, Schramm J, Wiestler OD, Deimling A: Molecular genetic evidence for subtypes of oligoastrocytomas. J Neuropathol Exp Neurol 1997, 56:1098-1104
23. Zhu J, Santarius T, Wu Xiaoyun, Tsong J, Guha A, Wu JK, Hudson TJ, Black PM: Screening for loss of heterozygosity and microsatellite instability in oligodendrogliomas. Genes Chromosom Cancer 1998, 21:207-216
24. Kleihues P, Ohgaki H: Plenary Lecture PL2.1. Genetics of glioma progression and the definition of primary and secondary glioblastoma. Brain Pathol 1997, 7:1131-1136
25. Kraus JA, Koopmann J, Kaskel P, Mantz D, Brandner S, Schramm J, Louis DN, Wiestler OD, von Deimling A: Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 1995, 54: 91-95